Moxifloxacin Pharmacokinetic Profile and Efficacy Evaluation in Empiric Treatment of Community-Acquired Pneumonia

When antimicrobials are used empirically, pathogen MICs equal to clinical breakpoints or epidemiological cutoff values must be considered. This is to ensure that the most resistant pathogen subpopulation is appropriately targeted to prevent emergence of resistance. Accordingly, we determined the pha...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Öbrink-Hansen, Kristina, Hardlei, Tore Forsingdal, Brock, Birgitte, Jensen-Fangel, Søren, Kragh Thomsen, Marianne, Petersen, Eskild, Kreilgaard, Mads
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2015
Matèries:
Clinical Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4356773/
https://ncbi.nlm.nih.gov/pubmed/25666151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.04659-14
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars